C.R.S. Section 18-18-303
Registration


(1)

The board or BHA shall register an applicant to manufacture or distribute substances included in schedules I through V unless the board or BHA determines that the issuance of that registration would be inconsistent with the public interest. In determining the public interest, the board or BHA shall consider the following factors:

(a)

Maintenance of effective controls against diversion of controlled substances into other than legitimate medical, scientific, research, or industrial channels;

(b)

Compliance with applicable state and local law;

(c)

Promotion of technical advances in the art of manufacturing controlled substances and the development of new substances;

(d)

Any convictions of the applicant under any laws of another country or federal or state laws relating to any controlled substance;

(e)

Past experience of the applicant in the manufacture or distribution of controlled substances, and the existence in the applicant’s establishment of effective controls against diversion of controlled substances into other than legitimate medical, scientific, research, or industrial channels;

(f)

Furnishing by the applicant of false or fraudulent material in any application filed under this article;

(g)

Suspension or revocation of the applicant’s federal registration or the applicant’s registration of another state to manufacture, distribute, or dispense controlled substances as authorized by federal law; and

(h)

Any other factors relevant to and consistent with the public health and safety.

(2)

Registration under subsection (1) of this section entitles a registrant to manufacture or distribute a substance included in schedule I or II only if it is specified in the registration.

(3)

A practitioner must be registered with the board or BHA before dispensing a controlled substance or conducting research with respect to a controlled substance included in schedules II through V. The BHA need not require separate registration under this article 18 for practitioners engaging in research with nonnarcotic substances included in schedules II through V where the registrant is already registered under this article 18 in another capacity. Practitioners registered under federal law to conduct research with substances included in schedule I may conduct research with substances included in schedule I within this state upon furnishing the BHA evidence of that federal registration.

(4)

A manufacturer or distributor registered under the federal “Controlled Substances Act”, 21 U.S.C. sec. 801 et seq., may submit a copy of the federal application as an application for registration as a manufacturer or distributor under this section. The board may require a manufacturer or distributor to submit information in addition to the application for registration under the federal act.

(5)

Persons licensed or registered under article 280 of title 12 or article 220, 240, 275, 290, or 315 of title 12 need not be licensed separately to distribute or dispense controlled substances to the extent provided under law if they are registered or are exempt from registration by the federal drug enforcement administration, provided that such persons indicate on any initial application or renewal application the schedules of controlled substances that the persons are authorized to use under Public Law 91-513, known as the federal “Comprehensive Drug Abuse Prevention and Control Act of 1970”.

Source: Section 18-18-303 — Registration, https://leg.­colorado.­gov/sites/default/files/images/olls/crs2023-title-18.­pdf (accessed Oct. 20, 2023).

18‑18‑101
Short title
18‑18‑102
Definitions
18‑18‑103
Special definition - board
18‑18‑201
Authority to control
18‑18‑202
Nomenclature
18‑18‑203
Schedule I
18‑18‑204
Schedule II
18‑18‑205
Schedule III
18‑18‑206
Schedule IV - repeal
18‑18‑207
Schedule V
18‑18‑301
Rules
18‑18‑302
Registration requirements - definitions
18‑18‑303
Registration
18‑18‑304
Suspension or revocation of registration
18‑18‑305
Order to show cause
18‑18‑306
Records of registrants
18‑18‑307
Order forms
18‑18‑308
Prescriptions
18‑18‑309
Diversion prevention and control
18‑18‑401
Legislative declaration
18‑18‑402
Definitions - terms used
18‑18‑403
Additional definition
18‑18‑403.5
Unlawful possession of a controlled substance - notice to revisor of statutes - repeal
18‑18‑404
Unlawful use of a controlled substance
18‑18‑405
Unlawful distribution, manufacturing, dispensing, or sale
18‑18‑406
Offenses relating to marijuana and marijuana concentrate - definitions
18‑18‑406.1
Unlawful use or possession of synthetic cannabinoids or salvia divinorum
18‑18‑406.2
Unlawful distribution, manufacturing, dispensing, sale, or cultivation of synthetic cannabinoids or salvia divinorum
18‑18‑406.3
Medical use of marijuana by persons diagnosed with debilitating medical conditions - unlawful acts - penalty - medical marijuana program cash fund
18‑18‑406.4
Unlawful advertising of marijuana - exception
18‑18‑406.5
Unlawful use of marijuana in a detention facility
18‑18‑406.6
Extraction of marijuana concentrate - definitions
18‑18‑406.9
Unlawful distribution or purchase of dextromethorphan - penalty - preemption - definitions
18‑18‑407
Special offender - definitions
18‑18‑409
Reduction or suspension of sentence for providing substantial assistance
18‑18‑410
Declaration of class 1 public nuisance
18‑18‑411
Keeping, maintaining, controlling, renting, or making available property for unlawful distribution or manufacture of controlled substances
18‑18‑412
Abusing toxic vapors - prohibited
18‑18‑412.5
Unlawful possession of materials to make methamphetamine and amphetamine - penalty
18‑18‑412.7
Sale or distribution of materials to manufacture controlled substances
18‑18‑412.8
Retail sale of methamphetamine precursor drugs - unlawful acts - penalty
18‑18‑413
Authorized possession of controlled substances
18‑18‑414
Unlawful acts - licenses - penalties
18‑18‑415
Fraud and deceit
18‑18‑416
Controlled substances - inducing consumption by fraudulent means
18‑18‑417
Notice of conviction
18‑18‑418
Exemptions
18‑18‑419
Imitation and counterfeit controlled substances act
18‑18‑420
Imitation controlled substances - definitions
18‑18‑421
Imitation controlled substances - determination - considerations
18‑18‑422
Imitation controlled substances - violations - penalties
18‑18‑423
Counterfeit substances prohibited - penalty
18‑18‑424
Imitation controlled substances - exceptions
18‑18‑425
Drug paraphernalia - legislative declaration
18‑18‑426
Drug paraphernalia - definitions
18‑18‑427
Drug paraphernalia - determination - considerations
18‑18‑428
Possession of drug paraphernalia - penalty
18‑18‑429
Manufacture, sale, or delivery of drug paraphernalia - penalty
18‑18‑430
Advertisement of drug paraphernalia - penalty
18‑18‑430.5
Drug paraphernalia - exemption
18‑18‑431
Defenses
18‑18‑432
Drug offender public service and rehabilitation program - definitions
18‑18‑433
Constitutional provisions
18‑18‑434
Offenses relating to natural medicine and natural medicine product - definitions
18‑18‑501
Administrative inspections and warrants
18‑18‑502
Injunctions
18‑18‑503
Cooperative arrangements and confidentiality
18‑18‑504
Pleadings - presumptions - liabilities
18‑18‑505
Judicial review
18‑18‑506
Education and research
18‑18‑601
Pending proceedings - applicability
18‑18‑602
Continuation of rules - application to existing relationships
18‑18‑603
Statutes of limitations
18‑18‑604
Uniformity of interpretation
18‑18‑605
Severability
18‑18‑606
Drug case data collection
18‑18‑607
Safe stations - disposal of controlled substances - medical evaluation - definition
Green check means up to date. Up to date

Current through Fall 2024

§ 18-18-303’s source at colorado​.gov